W. Maclaughlin

Statistics

Publications

Citations

H-Index

Active since

1986

Affiliations

Columbia University(Current)

Presbyterian Medical Center

W. Maclaughlin is an author at Columbia University specializing in chemotherapy in hematologic malignancies, acute myeloid leukemia treatment, and hematology.

Publications per year

1986–1989

Publications

Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity

Kapil N. Bhalla, W. Maclaughlin, Joby Cole et al. · Blood · 1987 · 33 citations · Full text

Medicine, Hematology, Oncology +14

2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity

Kapil N. Bhalla, Martin Birkhofer, Steven Grant et al. · Blood · 1989 · 19 citations · Full text

Public Health, Pharmacology, Hiv Prevention +5

Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1

Kapil N. Bhalla, Joby Cole, W. Maclaughlin et al. · Blood · 1986 · 12 citations · Full text

Life Sciences, Biochemistry, Cell Biology +3

1–3 of 3